Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	axonemal dynein complex assembly	DNAH2 DAW1 DNAH17 DNAI2 DNAI4	1.88e-05	41	166	5	GO:0070286
GeneOntologyCellularComponent	dynein complex	DNAH2 DYNLT3 DYNLT1 DNAH17 DNAI2 DNAI4	4.32e-06	54	166	6	GO:0030286
GeneOntologyCellularComponent	microtubule associated complex	KIF23 NDE1 DNAH2 DYNLT3 DYNLT1 DNAH17 DNAI2 DNAI4 FBXW11	5.75e-06	161	166	9	GO:0005875
GeneOntologyCellularComponent	axonemal dynein complex	DNAH2 DNAH17 DNAI2 DNAI4	4.26e-05	25	166	4	GO:0005858
Domain	TSP_1	THSD7A ADAMTS1 ADAMTS13 CCN1 SEMA5B ADAMTS17 C8A	1.24e-06	63	163	7	PF00090
Domain	TSP1	THSD7A ADAMTS1 ADAMTS13 CCN1 SEMA5B ADAMTS17 C8A	1.54e-06	65	163	7	SM00209
Domain	TSP1_rpt	THSD7A ADAMTS1 ADAMTS13 CCN1 SEMA5B ADAMTS17 C8A	1.54e-06	65	163	7	IPR000884
Domain	TSP1	THSD7A ADAMTS1 ADAMTS13 CCN1 SEMA5B ADAMTS17 C8A	1.54e-06	65	163	7	PS50092
Domain	WD40_repeat	MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 HERC2 MLST8 FBXW11	4.93e-06	272	163	12	IPR001680
Domain	WD_REPEATS_1	MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 HERC2 MLST8 FBXW11	6.16e-06	278	163	12	PS00678
Domain	WD_REPEATS_2	MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 HERC2 MLST8 FBXW11	6.39e-06	279	163	12	PS50082
Domain	WD_REPEATS_REGION	MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 HERC2 MLST8 FBXW11	6.39e-06	279	163	12	PS50294
Domain	-	SEMA6C MED16 WDFY4 HIRA STRN SEMA5B CIAO1 DAW1 DNAI2 WDR89 DNAI4 MLST8 FBXW11	7.45e-06	333	163	13	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	SEMA6C MED16 WDFY4 HIRA STRN SEMA5B CIAO1 DAW1 DNAI2 WDR89 DNAI4 MLST8 FBXW11	7.95e-06	335	163	13	IPR015943
Domain	WD40_repeat_dom	KNTC1 MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 MLST8 FBXW11	1.20e-05	297	163	12	IPR017986
Domain	WD40	MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 MLST8 FBXW11	1.76e-05	259	163	11	PF00400
Domain	WD40	MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 MLST8 FBXW11	2.42e-05	268	163	11	SM00320
Domain	Miga	MIGA2 MIGA1	7.57e-05	2	163	2	IPR019392
Domain	Miga	MIGA2 MIGA1	7.57e-05	2	163	2	PF10265
Domain	PHD_4	KDM2B KDM2A	2.26e-04	3	163	2	PF16866
Domain	DUF1693	TENT5C TENT5B	4.49e-04	4	163	2	IPR012937
Domain	DUF1693	TENT5C TENT5B	4.49e-04	4	163	2	SM01153
Domain	NTP_transf_7	TENT5C TENT5B	4.49e-04	4	163	2	PF07984
Domain	Leu-rich_rpt_Cys-con_subtyp	RNH1 KDM2B KDM2A	5.71e-04	19	163	3	IPR006553
Domain	LRR_CC	RNH1 KDM2B KDM2A	5.71e-04	19	163	3	SM00367
Domain	WD40_repeat_CS	WDFY4 HIRA STRN CIAO1 DAW1 MLST8 FBXW11	6.00e-04	164	163	7	IPR019775
Domain	Sushi	CD55 CR2 SUSD1 CSMD1	1.09e-03	52	163	4	PF00084
Domain	Tctex-1	DYNLT3 DYNLT1	1.11e-03	6	163	2	PF03645
Domain	MANSC	KIAA0319L MANSC4	1.11e-03	6	163	2	PS50986
Domain	MANSC_dom	KIAA0319L MANSC4	1.11e-03	6	163	2	IPR013980
Domain	Tctex	DYNLT3 DYNLT1	1.11e-03	6	163	2	IPR005334
Domain	Peptidase_M12B_ADAM-TS	ADAMTS1 ADAMTS13 ADAMTS17	1.15e-03	24	163	3	IPR013273
Domain	CCP	CD55 CR2 SUSD1 CSMD1	1.26e-03	54	163	4	SM00032
Domain	SUSHI	CD55 CR2 SUSD1 CSMD1	1.44e-03	56	163	4	PS50923
Domain	Sushi_SCR_CCP_dom	CD55 CR2 SUSD1 CSMD1	1.54e-03	57	163	4	IPR000436
Domain	ADAM_Cys-rich	ADAMTS1 ADAMTS13 ADAMTS17	1.64e-03	27	163	3	IPR006586
Domain	ACR	ADAMTS1 ADAMTS13 ADAMTS17	1.64e-03	27	163	3	SM00608
Domain	ZINC_PROTEASE	OMA1 ADAMTS1 ADAMTS13 ERAP2 ADAMTS17	1.68e-03	98	163	5	PS00142
Domain	ETS_DOMAIN_1	ERG ETS2 ETV2	1.82e-03	28	163	3	PS00345
Domain	ETS_DOMAIN_2	ERG ETS2 ETV2	1.82e-03	28	163	3	PS00346
Domain	Ets	ERG ETS2 ETV2	1.82e-03	28	163	3	PF00178
Domain	ETS	ERG ETS2 ETV2	1.82e-03	28	163	3	SM00413
Domain	Ets_dom	ERG ETS2 ETV2	1.82e-03	28	163	3	IPR000418
Domain	ETS_DOMAIN_3	ERG ETS2 ETV2	1.82e-03	28	163	3	PS50061
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD7A ADAMTS1 ADAMTS13 SEMA5B ADAMTS17	1.59e-05	39	116	5	M27417
Pathway	REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS	THSD7A ADAMTS1 ADAMTS13 SEMA5B ADAMTS17	1.59e-05	39	116	5	MM15165
Pathway	KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE	KNTC1 NDE1 DYNLT3 DYNLT1	1.01e-04	30	116	4	M47889
Pubmed	Fli1 acts downstream of Etv2 to govern cell survival and vascular homeostasis via positive autoregulation.	ERG ETS2 ETV2 TEK	9.81e-07	16	171	4	24727028
Pubmed	Vertebrate Dynein-f depends on Wdr78 for axonemal localization and is essential for ciliary beat.	DNAH2 DYNLT1 DNAI4	1.16e-06	5	171	3	30060180
Pubmed	O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation.	THSD7A ADAMTS1 ADAMTS13 CCN1 SEMA5B ADAMTS17	1.97e-06	75	171	6	20637190
Pubmed	A unified taxonomy for ciliary dyneins.	DAW1 DNAI2 DNAI4	2.31e-06	6	171	3	21953912
Pubmed	The gene encoding disabled-1 (DAB1), the intracellular adaptor of the Reelin pathway, reveals unusual complexity in human and mouse.	OMA1 LEPR C8A	2.31e-06	6	171	3	12446734
Pubmed	Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins.	EPRS1 CCT3 GGT6 NSD1 ABCC11 DIPK2B FZD8 DCANP1 SPATA17 ZBTB25 ZNF728 CIAO1 DNAI2 SCNN1G C9orf50 CSMD1	3.94e-06	832	171	16	36724073
Pubmed	Identification of the dynein light chains required for human papillomavirus infection.	DYNLT3 DYNLT1	2.40e-05	2	171	2	21166973
Pubmed	Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2.	FASN MUC2	2.40e-05	2	171	2	22341463
Pubmed	Identification of binding domains in the herpes simplex virus type 1 small capsid protein pUL35 (VP26).	DYNLT3 DYNLT1	2.40e-05	2	171	2	20668116
Pubmed	Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas.	KDM2B KDM2A	2.40e-05	2	171	2	32901907
Pubmed	Autoantigens PLA2R and THSD7A in membranous nephropathy share a common epitope motif in the N-terminal domain.	THSD7A PLA2R1	2.40e-05	2	171	2	31395435
Pubmed	Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking.	HEATR5A HEATR5B	2.40e-05	2	171	2	38240799
Pubmed	Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.	THSD7A PLA2R1	2.40e-05	2	171	2	29511687
Pubmed	Ubiquitin specific peptidase 38 promotes the progression of gastric cancer through upregulation of fatty acid synthase.	FASN USP38	2.40e-05	2	171	2	35812059
Pubmed	Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.	THSD7A PLA2R1	2.40e-05	2	171	2	33249733
Pubmed	Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.	THSD7A PLA2R1	2.40e-05	2	171	2	28904948
Pubmed	KIF23 promotes cervical cancer progression via inhibiting NLRP3-mediated pyroptosis.	KIF23 NLRP3	2.40e-05	2	171	2	38780518
Pubmed	Comprehensively characterizing cellular changes and the expression of THSD7A and PLA2R1 under multiple in vitro models of podocyte injury.	THSD7A PLA2R1	2.40e-05	2	171	2	35670653
Pubmed	A new lymphocyte alloantigen (Ly-10) controlled by a gene linked to the Lyt-1 locus.	SLC3A2 CD5	2.40e-05	2	171	2	22457928
Pubmed	FAM46B is a prokaryotic-like cytoplasmic poly(A) polymerase essential in human embryonic stem cells.	TENT5C TENT5B	2.40e-05	2	171	2	32009146
Pubmed	Further genetic characterization of mouse Ly-m10 alloantigen.	SLC3A2 CD5	2.40e-05	2	171	2	6402449
Pubmed	Biological Functions of the KDM2 Family of Histone Demethylases.	KDM2B KDM2A	2.40e-05	2	171	2	37751135
Pubmed	Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.	LEPR NLRP3	2.40e-05	2	171	2	33675822
Pubmed	The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing.	LEPR CCN1	2.40e-05	2	171	2	26077348
Pubmed	Overexpression of Macrophage-Inducible C-Type Lectin Mincle Aggravates Proinflammatory Responses to Streptococcus pneumoniae with Fatal Outcome in Mice.	NLRP3 CLEC4E	2.40e-05	2	171	2	33158955
Pubmed	Mitoguardin-1 and -2 promote maturation and the developmental potential of mouse oocytes by maintaining mitochondrial dynamics and functions.	MIGA2 MIGA1	2.40e-05	2	171	2	26716412
Pubmed	The mouse Ly-12.1 specificity: genetic and biochemical relationship to Ly-1.	SLC3A2 CD5	2.40e-05	2	171	2	3356451
Pubmed	KDM2 proteins constrain transcription from CpG island gene promoters independently of their histone demethylase activity.	KDM2B KDM2A	2.40e-05	2	171	2	31363749
Pubmed	Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy.	THSD7A PLA2R1	2.40e-05	2	171	2	25394321
Pubmed	Bisphosphonate Induces Osteonecrosis of the Jaw in Diabetic Mice via NLRP3/Caspase-1-Dependent IL-1β Mechanism.	LEPR NLRP3	2.40e-05	2	171	2	26081624
Pubmed	Biomarkers to detect membranous nephropathy in Chinese patients.	THSD7A PLA2R1	2.40e-05	2	171	2	27634909
Pubmed	Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes.	LEPR FASN	2.40e-05	2	171	2	21389266
Pubmed	Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.	THSD7A PLA2R1	2.40e-05	2	171	2	26393352
Pubmed	Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics.	ADAMTS1 ADAMTS13 ADAMTS17	2.49e-05	12	171	3	25770910
Pubmed	Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2.	ERG ETS2 ETV2	3.22e-05	13	171	3	25802403
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MON2 KNTC1 NDE1 BAZ1B STRN CYFIP1 RESF1 NFATC3 CIAO1 N4BP2 KDM2B PPP6R3	3.76e-05	588	171	12	38580884
Pubmed	Cord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome.	IL18R1 NLRP3 CLEC4E	6.24e-05	16	171	3	23630357
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	KNTC1 EPRS1 CCT3 DDX60 FASN UTP20 HERC2	6.74e-05	202	171	7	33005030
Pubmed	Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.	NSD1 KDM2A	7.19e-05	3	171	2	34905470
Pubmed	Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma.	NSD1 KDM2A	7.19e-05	3	171	2	37311054
Pubmed	ERG is specifically associated with ETS-2 and ETV-4, but not with ETS-1, in prostate cancer.	ERG ETS2	7.19e-05	3	171	2	22922762
Pubmed	A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.	KDM2B KDM2A	7.19e-05	3	171	2	30033217
Pubmed	Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancers.	ERG CEACAM1	7.19e-05	3	171	2	32150281
Pubmed	ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation.	LEPR NLRP3	7.19e-05	3	171	2	36446229
Pubmed	Amplified segment in the 'Down syndrome critical region' on HSA21 shared between Down syndrome and euploid AML-M0 excludes RUNX1, ERG and ETS2.	ERG ETS2	7.19e-05	3	171	2	22221250
Pubmed	IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model.	IL18R1 NLRP3	7.19e-05	3	171	2	36758176
Pubmed	Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice.	LEPR NLRP3	7.19e-05	3	171	2	24194505
Pubmed	Immunogenetics of mouse B-cell alloantigen systems defined by monoclonal antibodies and gene-cluster formation of these loci.	SLC3A2 CD5	7.19e-05	3	171	2	6984005
Pubmed	Ligand-induced nuclear translocation of S1P(1) receptors mediates Cyr61 and CTGF transcription in endothelial cells.	S1PR1 CCN1	7.19e-05	3	171	2	18936953
Pubmed	Detailed mapping of the ERG-ETS2 interval of human chromosome 21 and comparison with the region of conserved synteny on mouse chromosome 16.	ERG ETS2	7.19e-05	3	171	2	14693372
Pubmed	Angiopoietin/Tie2 pathway mediates type 2 diabetes induced vascular damage after cerebral stroke.	TEK LEPR	7.19e-05	3	171	2	21515377
Pubmed	3' RNA Uridylation in Epitranscriptomics, Gene Regulation, and Disease.	TENT5C TENT5B	7.19e-05	3	171	2	30057901
Pubmed	Hypothalamic S1P/S1PR1 axis controls energy homeostasis.	S1PR1 LEPR	7.19e-05	3	171	2	25255053
Pubmed	Leptin Induces Hypertension Acting on Transient Receptor Potential Melastatin 7 Channel in the Carotid Body.	TRPM7 LEPR	7.19e-05	3	171	2	31545149
Pubmed	Gene body hypomethylation of pyroptosis-related genes NLRP7, NLRP2, and NLRP3 facilitate non-invasive surveillance of hepatocellular carcinoma.	NLRP7 NLRP3	7.19e-05	3	171	2	37273114
Pubmed	Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress.	CR2 S1PR1	7.19e-05	3	171	2	23263181
Pubmed	Kdm2a/b Lysine Demethylases Regulate Canonical Wnt Signaling by Modulating the Stability of Nuclear β-Catenin.	KDM2B KDM2A	7.19e-05	3	171	2	26004508
Pubmed	ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.	ERG ETS2	7.19e-05	3	171	2	19168790
Pubmed	Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59.	IL18R1 NLRP3	7.19e-05	3	171	2	21270336
Pubmed	cDNA cloning of human oxysterol-binding protein and localization of the gene to human chromosome 11 and mouse chromosome 19.	SLC3A2 CD5	7.19e-05	3	171	2	1970801
Pubmed	Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.	NSD1 KDM2A	7.19e-05	3	171	2	20080798
Pubmed	Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway.	S1PR1 LEPR	7.19e-05	3	171	2	26948947
Pubmed	Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region.	CR2 NFATC3	1.43e-04	4	171	2	11907091
Pubmed	Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.	NLRP3 ZNF746	1.43e-04	4	171	2	35654037
Pubmed	Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells.	LEPR FASN	1.43e-04	4	171	2	17369526
Pubmed	Spliceosome-Associated Protein 130 Exacerbates Alcohol-Induced Liver Injury by Inducing NLRP3 Inflammasome-Mediated IL-1β in Mice.	NLRP3 CLEC4E	1.43e-04	4	171	2	29355515
Pubmed	De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation.	LEPR FASN	1.43e-04	4	171	2	21098489
Pubmed	Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy.	LEPR NLRP3	1.43e-04	4	171	2	25075770
Pubmed	NSD1 mediates antagonism between SWI/SNF and polycomb complexes and is required for transcriptional activation upon EZH2 inhibition.	NSD1 KDM2A	1.43e-04	4	171	2	35537449
Pubmed	ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia.	ADAMTS1 ADAMTS13	1.43e-04	4	171	2	29135310
Pubmed	The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity.	LEPR NLRP3	1.43e-04	4	171	2	21109192
Pubmed	Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.	CD5 NFATC3	1.43e-04	4	171	2	14595020
Pubmed	Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation.	IL10RA NLRP3	1.43e-04	4	171	2	26412089
Pubmed	Histone demethylation by a family of JmjC domain-containing proteins.	KDM2B KDM2A	1.43e-04	4	171	2	16362057
Pubmed	The pore-forming subunit Kir6.1 of the K-ATP channel negatively regulates the NLRP3 inflammasome to control insulin resistance by interacting with NLRP3.	LEPR NLRP3	1.43e-04	4	171	2	31387986
Pubmed	The selection of marginal zone B cells differs from that of B-1a cells.	CR2 CD5	1.43e-04	4	171	2	14662849
Pubmed	SphK1 Promotes Cancer Progression through Activating JAK/STAT Pathway and Up-Regulating S1PR1 Expression in Colon Cancer Cells.	S1PR1 SPHKAP	1.43e-04	4	171	2	33797381
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	CYP20A1 CD55 BAZ1B TENT5C NHLRC2 NACAD PTH1R HIRA ZCCHC14 CYFIP1 MIGA2 DNAH17 MEDAG WDR89 ZSCAN2 CSMD1 FGGY	1.44e-04	1242	171	17	30973865
Pubmed	Molecular genetics of successful smoking cessation: convergent genome-wide association study results.	ERG TEK WDFY4 MYO18B CSMD1	1.47e-04	101	171	5	18519826
Pubmed	New nomenclature for chromatin-modifying enzymes.	NSD1 PRDM2 KDM2B KDM2A	1.82e-04	57	171	4	18022353
Pubmed	mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.	SIPA1L1 MLST8 FBXW11	1.92e-04	23	171	3	22017875
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	MON2 SCFD2 TMEM201 TRPM7 KIAA0319L SLC3A2 TENM1 MIGA1 HEATR5B FBXW11	2.11e-04	504	171	10	34432599
Pubmed	ETS-dependent regulation of a distal Gata4 cardiac enhancer.	ERG ETS2 ETV2	2.19e-04	24	171	3	22056786
Pubmed	Systematic analysis and nomenclature of mammalian F-box proteins.	FBXO43 KDM2B KDM2A FBXW11	2.37e-04	61	171	4	15520277
Pubmed	Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human.	SLC3A2 CD5	2.38e-04	5	171	2	9027487
Pubmed	Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor.	DYNLT3 DYNLT1	2.38e-04	5	171	2	22028875
Pubmed	Mitochondrial Function Regulated by Mitoguardin-1/2 Is Crucial for Ovarian Endocrine Functions and Ovulation.	MIGA2 MIGA1	2.38e-04	5	171	2	28938432
Pubmed	Toll-like receptor and inflammasome signals converge to amplify the innate bactericidal capacity of T helper 1 cells.	IL18R1 NLRP3	2.38e-04	5	171	2	24508233
Pubmed	Localization of the gene for plasma retinol binding protein to the distal half of mouse chromosome 19.	SLC3A2 CD5	2.38e-04	5	171	2	2004789
Pubmed	Fas-associated factor 1 is a negative regulator of PYRIN-containing Apaf-1-like protein 1.	NLRP7 NLRP3	2.38e-04	5	171	2	17046979
Pubmed	Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport.	DYNLT3 DYNLT1	2.38e-04	5	171	2	15117959
Pubmed	Mouse lipocortin I gene structure and chromosomal assignment: gene duplication and the origins of a gene family.	SLC3A2 CD5	2.38e-04	5	171	2	1676980
Pubmed	Mitoguardin Regulates Mitochondrial Fusion through MitoPLD and Is Required for Neuronal Homeostasis.	MIGA2 MIGA1	2.38e-04	5	171	2	26711011
Pubmed	An integrated deletion and physical map encompassing l71Rl, a chromosome 7 locus required for peri-implantation survival in the mouse.	CYFIP1 HERC2	2.38e-04	5	171	2	10903848
Pubmed	Nlrp3-dependent IL-1β inhibits CD103+ dendritic cell differentiation in the gut.	IL18R1 NLRP3	2.38e-04	5	171	2	29515025
Pubmed	The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner.	ERG ETS2	2.38e-04	5	171	2	9334186
Pubmed	Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability.	MIGA2 MIGA1	2.38e-04	5	171	2	29180626
Pubmed	Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study.	ADAMTS1 S1PR1 STRN HEATR5B	2.52e-04	62	171	4	17975119
Pubmed	Gene variants associated with ischemic stroke: the cardiovascular health study.	ADAMTS1 S1PR1 STRN HEATR5B	2.68e-04	63	171	4	19023099
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEMA6C KIF26A NACAD TIAM2 USP38 SEMA5B MED12L KDM2B MED13 PPP6R3	3.10e-04	529	171	10	14621295
Cytoband	9q34.11	OR1J4 OR1J2 MIGA2 C9orf50	4.72e-05	53	171	4	9q34.11
GeneFamily	WD repeat domain containing	MED16 WDFY4 HIRA STRN CIAO1 DAW1 DNAI2 WDR89 DNAI4 MLST8 FBXW11	9.03e-07	262	115	11	362
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	IL10RA CD55 TEK CR2 IL18R1 S1PR1 LEPR CEACAM1 CD5 KLRC2 PTGDR2	4.29e-05	394	115	11	471
GeneFamily	Dyneins, axonemal	DNAH2 DNAH17 DNAI2	1.60e-04	17	115	3	536
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS1 ADAMTS13 ADAMTS17	2.26e-04	19	115	3	50
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CD55 CR2 SUSD1 CSMD1	4.73e-04	57	115	4	1179
GeneFamily	ETS transcription factor family	ERG ETS2 ETV2	7.31e-04	28	115	3	534
GeneFamily	Cyclins\|Mediator complex	MED16 MED12L MED13	1.19e-03	33	115	3	1061
GeneFamily	Zinc fingers CXXC-type	KDM2B KDM2A	2.54e-03	12	115	2	136
GeneFamily	PHD finger proteins	NSD1 BAZ1B KDM2B KDM2A	2.61e-03	90	115	4	88
GeneFamily	Dyneins, cytoplasmic	DYNLT3 DYNLT1	2.99e-03	13	115	2	538
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	ARHGAP24 THSD7A ERG TEK S1PR1 DIPK2B SORCS2 MEDAG FST	6.24e-08	193	171	9	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ERG ETS2 TEK CEACAM1 DIPK2B USP31 SEMA5B STC2	4.95e-07	180	171	8	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	Endothelial-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B STC2	7.16e-07	189	171	8	04b565855f58ca0f343904d04be657b66e109076
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD7A ERG ADAMTS1 KIF26A TEK S1PR1 LEPR DIPK2B	7.45e-07	190	171	8	ec6b8e2852e1cce0217ff61243defe98b2351640
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD7A ERG KIF26A TEK LEPR DIPK2B USP31 STC2	8.06e-07	192	171	8	0aeb5351275c0a91151ea2d52b2cdde172da6731
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	THSD7A ERG TEK IL18R1 S1PR1 LEPR DIPK2B STC2	1.06e-06	199	171	8	993999adf346b4fd557989bc53c17eb0ccb996c9
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A ERG ETS2 TEK S1PR1 LEPR CEACAM1 DIPK2B	1.06e-06	199	171	8	f35e9c05d0a0339ff691b38564da7aad8e9218aa
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Capillary\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	THSD7A ERG TEK IL18R1 S1PR1 LEPR DIPK2B STC2	1.06e-06	199	171	8	89f4db619fbed90f7fdf6ece7a671e514b5c6d76
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	THSD7A ERG TEK IL18R1 S1PR1 LEPR DIPK2B STC2	1.06e-06	199	171	8	3fea92affacd4c1f588fa81807df35d6c69b7241
ToppCell	356C-Myeloid-Mast_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	ERG DNAH2 IL18R1 DPEP3 MED12L PTGDR2 PGBD5	1.73e-06	148	171	7	1668d8a9e680da335362744f36b05446c499347e
ToppCell	356C-Myeloid-Mast_cell-\|356C / Donor, Lineage, Cell class and subclass (all cells)	ERG DNAH2 IL18R1 DPEP3 MED12L PTGDR2 PGBD5	1.73e-06	148	171	7	18511ba10765eda937c5a710626361f7e6b9b321
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LINC00473 ERG ETS2 TEK CEACAM1 DIPK2B MYO18B	3.15e-06	162	171	7	c399b9e4854916a59f5cae2d8dbf19660f8759be
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP24 MCMDC2 CR2 SUSD1 N4BP2 PGAP1 MED12L	3.15e-06	162	171	7	e81dec1db8e5a808d96e58410c91961e5d065c94
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LINC00473 ERG ETS2 TEK CEACAM1 DIPK2B MYO18B	3.15e-06	162	171	7	a291248b693c771845174393934a782f1d8bd7ce
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	OMA1 KIAA0319L HEATR5A NHLRC2 WDFY4 NLRP3 MED12L	3.15e-06	162	171	7	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP24 MCMDC2 CR2 SUSD1 N4BP2 PGAP1 MED12L	3.15e-06	162	171	7	d19b469f64c9064cfb82dadb6c8135e28949a02a
ToppCell	facs-Lung-Endomucin_-18m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP24 MCMDC2 CR2 SUSD1 N4BP2 PGAP1 MED12L	3.15e-06	162	171	7	10c2aa047f33f48e4abe676236bbdb593079dd1d
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TMEM201 CCT3 NHLRC2 S1PR1 FZD8 LINS1 ZBTB25	4.00e-06	168	171	7	c7021748003e5949f7caf7b3291c5bad294948c1
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NHLRC2 S1PR1 KRT80 IHO1 USP31 DNAH17 C9orf50	4.67e-06	172	171	7	490745024730df6357f6c2b81d7a64e21557c0d5
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	COL4A4 NDNF THSD7A CD55 KRT80 CCN1 PGBD5	4.85e-06	173	171	7	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	droplet-Marrow-BM-1m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX60 TENT5B CEACAM1 TREML4 ZSCAN2 MYO18B MLST8	5.23e-06	175	171	7	c1c722db42da9b8a2a46e516ddb83d9be5e2e504
ToppCell	Endothelial-B-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	THSD7A ADAMTS1 TEK S1PR1 DIPK2B ZNF676 MEDAG	5.43e-06	176	171	7	b288116a4588a1f9db9d49af92cea118937c9201
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 ARHGAP24 CR2 NIBAN3 WDFY4 PRDM2 C1orf220	5.85e-06	178	171	7	be1d991c5a0a5be22f14f57d34ee1330f1a12963
ToppCell	Endothelial\|World / shred by cell class for turbinate	ERG ADAMTS1 TEK S1PR1 DIPK2B STC2 MEDAG	6.07e-06	179	171	7	052b2681974be00efb8503fa4e2c85d91d5ebd06
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B SNCAIP	6.07e-06	179	171	7	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THSD7A ERG ADAMTS1 S1PR1 DIPK2B SNCAIP SPHKAP	6.53e-06	181	171	7	e898ecb8d8f2eb2204225b7b0d665cadcd241139
ToppCell	Endothelial-A-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	7.53e-06	185	171	7	dee0b7ba2f338f0979d2306aedf52ac35a36b60c
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG TEK S1PR1 LEPR DIPK2B USP31 STC2	7.53e-06	185	171	7	808d5e880069aff8866cd2c733b9fe568a37701f
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP24 CD55 CR2 NIBAN3 TIAM2 PRDM2 RESF1	7.53e-06	185	171	7	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	THSD7A ERG ADAMTS1 KIF26A TEK LEPR CSMD1	7.80e-06	186	171	7	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THSD7A ERG S1PR1 DIPK2B CEP68 SNCAIP SPHKAP	7.80e-06	186	171	7	20340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP24 NLRP7 TENT5C MEI1 CR2 NIBAN3 PRDM2	8.08e-06	187	171	7	8089ae6ee59533a090fe0b19bdd057fba8fa11de
ToppCell	Control-Endothelial_cells-Arterial_endothelial_cells\|Control / group, cell type (main and fine annotations)	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR CSMD1	8.08e-06	187	171	7	81affaab3fe3e1daea45ada6445e906ddd33950e
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	ARHGAP24 CD55 TENT5C CR2 NIBAN3 WDFY4 PRDM2	8.36e-06	188	171	7	d1bc1316bbb8cfc39acc70f8680b14d19f536997
ToppCell	facs-MAT-Fat-3m-Lymphocytic-B_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD55 CR2 NIBAN3 WDFY4 S1PR1 NFATC3 PGAP1	8.36e-06	188	171	7	a7158b5c94e6b356877f016e52f2c24a3f5d24d2
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG TEK S1PR1 LEPR DIPK2B USP31 STC2	8.36e-06	188	171	7	789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	COL4A4 NDNF STC2 ADAMTS17 C8A	8.52e-06	72	171	5	0bc1df0405fe854e0364f44b9dacc39b115a9b77
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD7A ERG ETS2 TEK CEACAM1 DIPK2B SNCAIP	8.66e-06	189	171	7	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG TEK S1PR1 LEPR DIPK2B USP31 STC2	8.66e-06	189	171	7	e82211b9dc7540e7a183be2cbcfae39fdf503949
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LINC00473 ERG ADAMTS1 ETS2 S1PR1 DIPK2B STC2	8.66e-06	189	171	7	e002dbb2138a6264be23f3b8148275a0cef351ef
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG TEK CEACAM1 DIPK2B FZD8 SNCAIP SEMA5B	8.96e-06	190	171	7	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LINC00473 ADAMTS1 ETS2 S1PR1 DIPK2B STC2 PIGW	8.96e-06	190	171	7	a318d80dd5cc33d43048883b0e7844b5aa280aab
ToppCell	Endothelial-A-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	ERG ADAMTS1 TEK IL18R1 S1PR1 LEPR DIPK2B	8.96e-06	190	171	7	6e83fa0eb8cabe0ffb35375f16e6bf3755ec4977
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD7A ERG NDE1 KIF26A TEK S1PR1 CEACAM1	8.96e-06	190	171	7	eae5bcdb8a35f3fba4d25854c1a43f83f80832a2
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	THSD7A ERG NDE1 KIF26A TEK S1PR1 CEACAM1	8.96e-06	190	171	7	3346bfd0474828b3729cffa9f4cc57b04dd30443
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	8.96e-06	190	171	7	141266bf411ea675fbf889b20c1b08673c45ff95
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR CSMD1	9.27e-06	191	171	7	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THSD7A ERG ADAMTS1 KIF26A TEK S1PR1 LEPR	9.27e-06	191	171	7	04c7aa2e39fdd08ca24c10d43b29a5e41a73b9e0
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A4 ARHGAP24 CR2 NIBAN3 WDFY4 PRDM2 C1orf220	9.27e-06	191	171	7	5a9a592875fbd0b1429b48db29a760fdc9c2c856
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD7A ERG ETS2 TEK CEACAM1 DIPK2B STC2	9.27e-06	191	171	7	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THSD7A ERG ADAMTS1 KIF26A TEK S1PR1 LEPR	9.27e-06	191	171	7	db8dd6bbba803585bdd6a55d5c403d383f2e9acf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ETS2 TEK S1PR1 CEACAM1 DIPK2B SNCAIP	9.59e-06	192	171	7	25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell	facs-BAT-Fat-3m-Endothelial-nan\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERG ADAMTS1 TEK S1PR1 PTH1R DIPK2B CCN1	9.92e-06	193	171	7	e340064cd146deac03f2d0fd43e2e218bb6057c9
ToppCell	3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THSD7A ERG ADAMTS1 KIF26A TEK S1PR1 LEPR	9.92e-06	193	171	7	3a9fe4e709c09ec787c71bdd6b58a71c419896de
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	9.92e-06	193	171	7	c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	EPRS1 HEATR5A STRN USP38 N4BP2 MIGA1 MED13	9.92e-06	193	171	7	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A ERG TEK S1PR1 LEPR CEP68 SNCAIP	9.92e-06	193	171	7	2e72309607902dabe3218888b22a77fe941f3570
ToppCell	facs-BAT-Fat-3m-Endothelial-endothelial_cell\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERG ADAMTS1 TEK S1PR1 PTH1R DIPK2B CCN1	9.92e-06	193	171	7	a211b386fd0fb9da9937361d29d90925a72c9715
ToppCell	facs-BAT-Fat-3m-Endothelial\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERG ADAMTS1 TEK S1PR1 PTH1R DIPK2B CCN1	9.92e-06	193	171	7	3086c33f4d6fab66966818737f95ae4d6b2615b0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERG TEK S1PR1 CEACAM1 DIPK2B SNCAIP SEMA5B	1.03e-05	194	171	7	cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ETS2 TEK CEACAM1 DIPK2B SNCAIP SEMA5B	1.03e-05	194	171	7	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	IPF-Endothelial-VE_Peribronchial\|World / Disease state, Lineage and Cell class	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.06e-05	195	171	7	120296531bbc8080dcabacbd64733cc1dc34603a
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD7A ERG ADAMTS1 KIF26A CELA2A TEK S1PR1	1.06e-05	195	171	7	517af3e6784f02c382df6f5691945eefaa9ec4ae
ToppCell	IPF-Endothelial-VE_Peribronchial\|IPF / Disease state, Lineage and Cell class	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.06e-05	195	171	7	2c3ad3cb79f11119ac69c413a938d21199145040
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ERG ETS2 TEK S1PR1 CEACAM1 DIPK2B STC2	1.06e-05	195	171	7	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	Endothelial-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	ERG ADAMTS1 TEK S1PR1 DIPK2B CCN1 STC2	1.06e-05	195	171	7	c3a0aa34b672c99cb3a2a4e9218412dbd19da3ca
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LINC00473 ERG ETS2 TEK S1PR1 CEACAM1 DIPK2B	1.10e-05	196	171	7	023312af38f816a44b407e0daa32590d953caf99
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	THSD7A ERG ADAMTS1 ETS2 LEPR DIPK2B CCN1	1.10e-05	196	171	7	5609b2d93172a488b35d854298a3a4e504e17e28
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ETS2 TEK S1PR1 CEACAM1 DIPK2B SNCAIP	1.10e-05	196	171	7	95c5b8fd4ebfae1f42de9b1475c1161d4a80e515
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LINC00473 THSD7A ERG ADAMTS1 TEK S1PR1 LEPR	1.10e-05	196	171	7	cf7f384c1771274e766bab03ecc3dfbd13f2df60
ToppCell	5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ERG ADAMTS1 ETS2 TEK S1PR1 LEPR DIPK2B	1.13e-05	197	171	7	0542badae77d2f606c13cfaf361319495c354351
ToppCell	(4)_Blood_vessel\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	1.13e-05	197	171	7	1b82979a41ef46c814c82527a585900586d71260
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.13e-05	197	171	7	1a137af40697137bb9d2b5caf2b1ffda55f04461
ToppCell	Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.13e-05	197	171	7	f969685dee212f33a6f09e54c0cd1fd24ffef546
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMEM201 THSD7A ERG ETS2 TEK S1PR1 DIPK2B	1.13e-05	197	171	7	31bec97c3952c48031bd66a5dad16a70a61519c3
ToppCell	(4)_Endothelial_cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	1.13e-05	197	171	7	dd9abb43c23e7698433e455eacbf5b23b0a756c2
ToppCell	Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.13e-05	197	171	7	96d63a8d00583e2aa0a38412e2ae27e23f399493
ToppCell	distal-3-Endothelial-Bronchial_Vessel_2\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KIF26A LEPR DIPK2B CEP68 CCN1 STC2 DCLRE1A	1.17e-05	198	171	7	f701d06e3d7fd2192afae3698c5ec3c355e96da3
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	THSD7A ERG ADAMTS1 ETS2 TEK S1PR1 DIPK2B	1.17e-05	198	171	7	f7aa809040fa9f5782b92eec1f289d690eb5c7bd
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ETS2 TEK S1PR1 CEACAM1 DIPK2B SNCAIP	1.17e-05	198	171	7	259fbcc0f2ac281a3e4d693de45b986fe5e24841
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ETS2 TEK CEACAM1 DIPK2B SNCAIP SEMA5B	1.17e-05	198	171	7	07701c73137947ed4a27e225975329235bbb8734
ToppCell	ASK452-Endothelial-Endothelium\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	ERG ETS2 TEK S1PR1 LEPR DIPK2B STC2	1.17e-05	198	171	7	e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	1.17e-05	198	171	7	56b746e5791b47fe33a7872f0942ae0747b13d4a
ToppCell	Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	1.17e-05	198	171	7	531b0f88c95f813e3914c96749f591e80ca321d0
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NDNF ADAMTS1 ADAMTS13 SNCAIP CCN1 SPHKAP PLP1	1.21e-05	199	171	7	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ERG TEK S1PR1 LEPR PTH1R DIPK2B PTGDR2	1.21e-05	199	171	7	236b1417ed0875e98c6ec1ec714003bfce438d65
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG ETS2 TEK S1PR1 LEPR DIPK2B SNCAIP	1.21e-05	199	171	7	33f1669eeb701986b4dec409efdb6c06c3c41c2b
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.21e-05	199	171	7	6fb81388c5045e81c3849a7136bdff3f953f044e
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate\|COVID-19_Mild / Disease, condition lineage and cell class	COL4A4 ARHGAP24 CR2 NIBAN3 WDFY4 PRDM2 C1orf220	1.21e-05	199	171	7	1c6a08d01f6c1a2a4b6587d3a4522efbd03275e1
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL4A4 NDNF CD55 HEATR5A PTH1R CCN1 SCNN1G	1.21e-05	199	171	7	1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b
ToppCell	ASK452-Endothelial\|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq	ERG ETS2 TEK S1PR1 LEPR DIPK2B STC2	1.21e-05	199	171	7	0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5
ToppCell	Lung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	THSD7A ERG ETS2 TEK S1PR1 LEPR DIPK2B	1.25e-05	200	171	7	e6d36be0c4c569e27303bb4e4f34cd2187e9759d
ToppCell	3'-Adult-LargeIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	1.25e-05	200	171	7	74a3b9ec8faa1d187ad8b0d12f5c89bde2d7248e
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD7A ERG ADAMTS1 KIF26A TEK S1PR1 LEPR	1.25e-05	200	171	7	5ec31c1be6bcc4124e1489d136570f3de33cc2e9
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Macrophages\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	THSD7A ERG ETS2 TEK S1PR1 LEPR DIPK2B	1.25e-05	200	171	7	c0c51719cf81512c50bfcc2fed883c867e522d2a
ToppCell	Lung_Parenchyma-Severe-Myeloid-Macrophage\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	THSD7A ERG ETS2 TEK S1PR1 LEPR DIPK2B	1.25e-05	200	171	7	758840c31f2ddd7ccf7bf13252ebb48d33e89479
ToppCell	Tracheal-10x5prime-Endothelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.25e-05	200	171	7	71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	THSD7A ERG ADAMTS1 TEK S1PR1 LEPR DIPK2B	1.25e-05	200	171	7	cd3c638961144a2fc91c437a173cc37c7452fa74
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	THSD7A ERG ADAMTS1 TEK S1PR1 DIPK2B STC2	1.25e-05	200	171	7	9f889f7ff0b3ba2750aa757b94680a9f7014fd0d
ToppCell	distal-1-Endothelial-Bronchial_Vessel_2\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	THSD7A ERG ADAMTS1 TEK S1PR1 CCN1 STC2	1.25e-05	200	171	7	aa8f8a0271c1363981e6ca1b2c1f0a8eb2652602
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	NDE1 MED16 KIAA0319L NRG2 TENT5C TG ZNF3 MINDY3 CCN1 C8A FST	2.16e-07	195	167	11	5569_UP
Drug	cymarose	ADAMTS1 CR2 FASN C8A	5.67e-07	10	167	4	CID000441417
Drug	STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A	ADAMTS1 ETS2 CD55 SLC3A2 HIRA ZNF3 CCN1 STC2 FST SFT2D2	9.95e-07	182	167	10	6427_UP
Disease	Clumsiness - motor delay	MED12L MED13	2.81e-05	2	157	2	C0520947
Disease	Motor delay	MED12L MED13	8.41e-05	3	157	2	C1854301
Disease	severe acute respiratory syndrome, COVID-19	OMA1 THSD7A WDFY4 TG MALRD1 SEMA5B SORCS2 ADAMTS17 CSMD1 FGGY	1.49e-04	447	157	10	EFO_0000694, MONDO_0100096
Disease	gestational trophoblastic neoplasm (is_implicated_in)	NLRP7 MEI1	1.68e-04	4	157	2	DOID:3590 (is_implicated_in)
Disease	Complete hydatidiform mole	NLRP7 MEI1	1.68e-04	4	157	2	C0678213
Disease	social deprivation, COVID-19	ARHGAP24 ERG ADAMTS17	1.83e-04	21	157	3	EFO_0009696, MONDO_0100096
Disease	Delayed speech and language development	MED12L MED13	2.78e-04	5	157	2	C0454644
Disease	semenogelin-1 measurement	OMA1 C8A	4.16e-04	6	157	2	EFO_0802051
Disease	brain measurement, hippocampal volume	MALRD1 UTP20	4.16e-04	6	157	2	EFO_0004464, EFO_0005035
Disease	Abnormality of the eye	MED13 FBXW11	5.80e-04	7	157	2	C4316870
Disease	Malignant neoplasm of breast	ADAMTS1 ETS2 TEK LEPR ZCCHC14 FASN SEMA5B STC2 DAW1 N4BP2 SIPA1L1 TENM1 UTP20 HERC2 FST	6.39e-04	1074	157	15	C0006142
Disease	Lung diseases	PTH1R CLEC4E DNAI2 SCNN1G	8.10e-04	78	157	4	C0024115
Disease	urate measurement	COL4A4 NSD1 BAZ1B PTH1R SPATA17 MALRD1 TIGD2 USP38 NFATC3 ADAMTS17 MYO18B HEATR5B FST	1.04e-03	895	157	13	EFO_0004531
Disease	response to anticonvulsant	TDRD15 THSD7A LEPR SORCS2	1.12e-03	85	157	4	GO_0036277
Disease	hair colour measurement, eye colour measurement, skin pigmentation measurement	SLC24A5 HERC2	1.23e-03	10	157	2	EFO_0007009, EFO_0007822, EFO_0009764
Disease	WNT1-inducible-signaling pathway protein 1 measurement	TG C8A	1.23e-03	10	157	2	EFO_0008321
Disease	ankylosing spondylitis	FASN MALRD1 ERAP2 CSMD1	1.44e-03	91	157	4	EFO_0003898
Disease	progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian serous carcinoma	ERG ADAMTS17 MYO18B	1.46e-03	42	157	3	EFO_0004920, EFO_1001516, GO_0097328, MONDO_0009354
Disease	Liver carcinoma	KIF23 ADAMTS1 ADAMTS13 PTH1R DIPK2B FASN CCN1 CSMD1 FST	1.64e-03	507	157	9	C2239176
Disease	QRS complex, QRS duration	STRN SIPA1L1 HEATR5B	1.78e-03	45	157	3	EFO_0005054, EFO_0005055
Disease	Crohn Disease	NLRP3 ERAP2 MUC2	2.41e-03	50	157	3	C0010346
Disease	Kartagener syndrome (implicated_via_orthology)	DAW1 DNAI2	2.45e-03	14	157	2	DOID:0050144 (implicated_via_orthology)
Disease	femoral neck bone geometry	NSD1 PPP6R3	2.45e-03	14	157	2	EFO_0004511
Disease	health literacy measurement	ADAMTS1 UTP20 CSMD1	2.85e-03	53	157	3	EFO_0010104
Disease	pulse pressure measurement	TDRD15 ARHGAP24 ERG TRPM7 CYP20A1 CELA2A HEATR5A MEI1 CEP68 FASN CYFIP1 SPATA17 MALRD1 CCN1 DCLRE1A FGGY	3.15e-03	1392	157	16	EFO_0005763
Disease	amygdala volume change measurement	CSMD1 FGGY	3.21e-03	16	157	2	EFO_0021490
Disease	Drug habituation	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C0013170
Disease	Drug abuse	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C0013146
Disease	Prescription Drug Abuse	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C4316881
Disease	Substance-Related Disorders	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C0236969
Disease	Drug Use Disorders	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C0013222
Disease	Drug Dependence	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C1510472
Disease	Substance Dependence	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C0038580
Disease	Substance Use Disorders	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	TIAM2 PLA2R1 ZNF606 CSMD1	3.37e-03	115	157	4	C0029231
Disease	Substance abuse problem	TIAM2 PLA2R1 ZNF606 CSMD1	3.48e-03	116	157	4	C0740858
Disease	Antibody Deficiency Syndrome	LEPR C8A	3.63e-03	17	157	2	C0003257
Disease	Hypogammaglobulinemia	CD55 CR2	3.63e-03	17	157	2	C0086438
Disease	idiopathic dilated cardiomyopathy	OR2F2 THSD7A DNAH17	4.05e-03	60	157	3	EFO_0009094
Disease	sphingosine 1-phosphate measurement	OMA1 SORCS2	4.07e-03	18	157	2	EFO_0800185
Disease	uterine fibroid	SCFD2 DNAH2 DYNLT3 MYO18B CSMD1	4.33e-03	199	157	5	EFO_0000731
Disease	primary ciliary dyskinesia (implicated_via_orthology)	DAW1 DNAI2	4.53e-03	19	157	2	DOID:9562 (implicated_via_orthology)
Disease	Hypertriglyceridemia	TDRD15 BAZ1B	4.53e-03	19	157	2	EFO_0004211
Disease	sensorineural hearing loss (implicated_via_orthology)	DNAH17 DNAI2	4.53e-03	19	157	2	DOID:10003 (implicated_via_orthology)
Disease	urinary microalbumin measurement	MON2 COL4A4	5.02e-03	20	157	2	EFO_0010967
Disease	heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer	DNAH2 SEMA5B	5.02e-03	20	157	2	EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992
Disease	polymyositis	THSD7A IL18R1	5.02e-03	20	157	2	EFO_0003063

Protein segments in the cluster

Peptide	Gene	Start	Entry
STSSTCKNEAGTDAW	BHLHB9	96	Q6PI77
RAWSSHLISLSLTCS	DCANP1	201	Q8TF63
TLASSSCWDCAGLST	C9orf50	336	Q5SZB4
GSTTRTCLANLTWSG	CSMD1	3251	Q96PZ7
HSSGLSCLSQWKSVL	CEP68	171	Q76N32
GDIWDQASCSSSTTC	C8A	76	P07357
SERIWTCKSTGSSQL	BAZ1B	46	Q9UIG0
WSQCSKTCGTGISTR	CCN1	236	O00622
LSDSSNSSCITWEGT	ERG	321	P11308
CLSWSTASGVFTTTD	ABHD18	221	Q0P651
TRSSFGSCLIFESSW	C8orf89	16	P0DMQ9
QWAALCDSSSARSSL	CD5	296	P06127
SRKAAAWTSSSACLC	CFAP46	2656	Q8IYW2
CSFRLTKSLATGPWS	COL4A4	11	P53420
SWVLTAAHCISSSRT	CELA2A	66	P08217
WLQSKTGTECFSAST	DNAI2	271	Q9GZS0
LWVSALSCSFSLPAS	DIPK2B	21	Q9H7Y0
NLTSSLLSVCGWSQT	ADAMTS13	146	Q76LX8
WSTCSSTCGKGLQSR	ADAMTS17	981	Q8TE56
SAGSTQTLAQTCWSL	NSD1	2651	Q96L73
DAASTCSTLWCTGTS	ADAMTS1	501	Q9UHI8
SSANWILAASLLSCS	NIBAN3	641	Q86XR2
CASIHFSSSTWVTLS	NUDCD1	116	Q96RS6
ISSWAARFKALSTCG	OR52Z1P	211	P0C646
EENKSRWTCTSSGSS	CYFIP1	326	Q7L576
KSSPGLSDTIFCRWT	MINDY3	16	Q9H8M7
AVSWILSCASSLSHT	OR1J2	146	Q8NGS2
WVLISVSTAESCTSR	IL18R1	11	Q13478
CSTATSLEWANTCGI	LINS1	41	Q8NG48
SELTACCTVLSSEWL	MED12L	1036	Q86YW9
NFRCLLSLTSSSCWK	MCMDC2	286	Q4G0Z9
LSLTSSSCWKFTAIL	MCMDC2	291	Q4G0Z9
VACGSAHTLAWSTSK	HERC2	4306	O95714
LSRCSSQDNWLLSSS	IHO1	536	Q8IYA8
TCFCFSVLWLSTDAS	KIAA0319L	36	Q8IZA0
FSSRSLTGCWSAGTI	KRT80	41	Q6KB66
SSFCLISGSSVQWSD	CD55	201	P08174
TTFSRCLSKEWGSFL	DDX60	121	Q8IY21
ATCSADQTCKIWRTS	MLST8	236	Q9BVC4
RWNLTSCGTSVASSE	FAM199X	66	Q6PEV8
AWKRSNFSCASTSGV	FAM199X	261	Q6PEV8
SLSLCTLSTTLGVFW	OR51F2	86	Q8NH61
SSTVLSTTPKLCCLW	MUC2	1291	Q02817
SSSLDVCWRSLSLKS	CSNKA2IP	161	A0A1B0GTH6
ELLSDKSCQSFISWT	ETS2	371	P15036
GDRTIKVWSTSTCEF	FBXW11	381	Q9UKB1
VSTTLSSWSGHARKC	NRG2	331	O14511
LSECVKSLSFSSSWI	ABCC11	211	Q96J66
SASFNWDCSLILTGS	DAW1	266	Q8N136
FDKLRTCSSATVAWL	NDNF	456	Q8TB73
TCSSATVAWLGTQER	NDNF	461	Q8TB73
TSKTWLVSVALCTSV	MANSC4	281	A6NHS7
TCRWSTSTIQSLAES	LEPR	446	P48357
CSNSSSSNFEGLLWS	LAS1L	706	Q9Y4W2
RCSSKSTSLFETAWE	KNTC1	766	P50748
HGSSISSWLSEVSVC	KIF26A	1106	Q9ULI4
SSWLSEVSVCTADSR	KIF26A	1111	Q9ULI4
LSDSFKETALATACW	MIGA2	461	Q7L4E1
LALSSCSDLGISDWS	IL10RA	526	Q13651
SKEECCSTGRLSTSW	FST	51	P19883
YSCPSESTWKLAVSS	MON2	1451	Q7Z3U7
TGRSCTLLATSTWLS	OR10G8	136	Q8NGN5
GLSSDWCTQISLFSL	OR2F2	16	O95006
CRTLASASWLSGLTN	OR2I1P	141	Q8NGU4
NSSSFSLDQGWTLCI	FAAP100	531	Q0VG06
SWELGTTFCKLHSSI	PTGDR2	96	Q9Y5Y4
SISSGELRSLWTCDC	MEDAG	16	Q5VYS4
SKLTEGVSSCWFLTA	NHLRC2	626	Q8NBF2
LCASSQTSSIVECWS	MED16	296	Q9Y2X0
EHLSSSSEVLVWSSC	MEI1	331	Q5TIA1
SSEVLVWSSCNCLTL	MEI1	336	Q5TIA1
TALLCSAWLLTASFS	MEI1	1006	Q5TIA1
TVSWILSCTNALSHT	OR1J4	146	Q8NGS1
RSVTIWLFSSDCSSL	OVOL3	46	O00110
STSISHCESVLSIWS	PGBD5	176	Q8N414
SLTAESLCSVWKVSR	FBXO43	516	Q4G163
FETSSGNWTTACSLT	MALRD1	1731	Q5VYJ5
DKQSIDSATWSTSSC	ARHGAP24	546	Q8N264
IAGTDTTTNSLLWCL	CYP2U1	351	Q7Z449
SGKTLESWRSLCTRC	FZD8	606	Q9H461
WSTDLDSVATLCFKS	HEATR5A	206	Q86XA9
ALWLNSTGFTCSEST	HEATR5B	1536	Q9P2D3
GCSWSAVSALSTSSC	KDM2A	986	Q9Y2K7
LSGCSWIAVSALCSS	KDM2B	1156	Q8NHM5
STLRCTVDSQKTGTW	CR2	321	P20023
IRSKSTAAAGLCSWC	DNAH17	3231	Q9UFH2
CSWKSSVSSASVSSQ	C7orf61	126	Q8IZ16
LDTTLCSAWLLASSC	LINC00473	116	A8K010
LTCSTNDTGISIRWF	CEACAM1	346	P13688
SWKATGVTARSLCSL	FGGY	176	Q96C11
GATLSSTWFTLTCLN	SLC49A4	356	Q96SL1
STWFTLTCLNSITHL	SLC49A4	361	Q96SL1
LSNLVAKSTTSAWAC	GGT6	386	Q6P531
SSCFWDSSTDGSCTV	DYNLT1	81	P63172
CSWSLSQARLLTSFL	SLC3A2	431	P08195
WSFSCDLTKGLNVSS	DNAI4	476	Q5VTH9
WSSLSNSCLESDFTS	ERAP2	496	Q6P179
ASSCFWDTTSDGTCT	DYNLT3	81	P51808
TKSGVLCSLEERWSS	DCLRE1A	201	Q6PJP8
TAKLCTWAICFLTTS	CYP20A1	281	Q6UW02
LTFTCSTPWAESSTK	DPEP3	221	Q9H4B8
AVGSKDRSLSVWLTC	HIRA	301	P54198
AETCWKGTSSSLASF	ETV2	46	O00321
LTRGDLSSIRWVCSS	FASN	1536	P49327
SVSSPSLLQFWCCLS	C1orf220	101	Q5T0J3
TASWRILQASLSSLC	DNAH2	2091	Q9P225
GWNCISALSSCSTVL	S1PR1	181	P21453
ACSFKEWTLTTSLAQ	SCNN1G	456	P51170
SKEWTASSAFSSVCN	PRDM2	806	Q13029
SGSRCALLATSTWLS	OR10G9	136	Q8NGN4
SCSSISVASCISEWE	KIF23	716	Q02241
HCCWDLSTLLTSSQS	NLRP3	956	Q96P20
LNSSFKETAVASSCW	MIGA1	496	Q8NAN2
STSLTDWLACTSARS	SPATA17	211	Q96L03
SLSTSCWETLLDVIS	UTP20	356	O75691
SGDRWSRLKASSCES	SPHKAP	1071	Q2M3C7
SCSADGTLRLWNTTE	STRN	586	O43815
WLEFSATKLSSCDSF	EPRS1	81	P07814
SSLSWSTRIKGFIAC	SFT2D2	26	O95562
IVSEFSAWSECSKTC	THSD7A	196	Q9UPZ6
DLWNFISSSRGLLTC	TDRD15	886	B5MCY1
RTWEESLLACTSKNS	KLRC2	136	P26717
SSCSMEVLATCLSLW	RESF1	666	Q9HCM1
LISSSNSSSVWDTVC	SLC39A4	256	Q6P5W5
SSWKTGLATSLAVFC	SLC39A4	521	Q6P5W5
TSWCIKGRSFTSALT	SORCS2	681	Q96PQ0
CRDVIGWTSTDTSLK	SIPA1L1	901	O43166
DRSVSSSSWNCGIST	SNCAIP	41	Q9Y6H5
SSSWNCGISTLITNT	SNCAIP	46	Q9Y6H5
TTKAISRWSSLACNI	CCT3	161	P49368
WKCTALSATAITVTL	TENM1	316	Q9UKZ4
LRLWTDFCSLFSSNS	NLRP7	661	Q8WX94
TCTAYWSGLLSSASV	PGAP1	691	Q75T13
CLSQSSDTTAKALWE	SCFD2	331	Q8WU76
TNSSSVWTLGLLRCF	MED13	1656	Q9UHV7
SLSNWRKCNTLASTS	OMA1	21	Q96E52
NLLSSLSWSEAHSSC	PLA2R1	246	Q13018
LCSFSPTWKTRFLTD	PIGW	46	Q7Z7B1
CTDSDRWSLISLSNK	TENT5B	181	Q96A09
CTDTDRWSLISLSNK	TENT5C	146	Q5VWP2
LTLSACWDSFETTRS	ABHD1	226	Q96SE0
TVESLSKTWCAQDSS	BCL2L15	91	Q5TBC7
SLKTSDVSWCLSDSG	ACSM1	256	Q08AH1
VSALCSRYCTSALWS	AQP11	126	Q8NBQ7
SGNLLATCSRDKSVW	CIAO1	116	O76071
TDTISWALSLKNCSA	CLEC4E	96	Q9ULY5
FSCSWLQLGLTSTAR	C11orf42	166	Q8N5U0
CDSWSDVSLKSSRLS	ZBTB25	396	P24278
WFDSRSSDSSCQVLT	TIGD2	431	Q4W5G0
CEECGKAFSWSSSLT	ZNF676	311	Q8N7Q3
CLTCGESFSWSSNLL	ZSCAN2	476	Q7Z7L9
CNECGKTFSWSSTLT	ZNF3	286	P17036
RWTVFSSSVACALLS	TMEM54	91	Q969K7
SRCTLLVTSSKPWTA	TREML4	61	Q6UXN2
DTKATLCTSWSDSDL	TIAM2	976	Q8IVF5
SVRATLANTGCWDLS	PTH1R	341	Q03431
QESSWEKGSSLSSCV	SPATA31D1	1371	Q6ZQQ2
WGSLCSILSFCTSAI	STC2	201	O76061
CTEKGTWRESTLTCT	SUSD1	281	Q6UWL2
ECGKVFSWSSSLTTH	ZNF728	456	P0DKX0
WLTTCGRSELKVFDS	WDFY4	346	Q6ZS81
ACGLLSNTVSTLSCW	SLC24A5	156	Q71RS6
SSRSWFSDASSCESL	NFATC3	171	Q12968
WLADCDVSDSSCSSL	RNH1	376	P13489
WDSQTLLACGTNSFS	SEMA6C	131	Q9H3T2
RCSTLEDSSNMSLWT	SEMA5B	581	Q9P283
WLDTLKFSTTSLCCL	TMEM201	351	Q5SNT2
SDAETSLTCIASGWR	TEK	36	Q02763
AWTSQSNSLASCLSR	USP38	421	Q8NB14
QSWLSCTLSLATDTM	MYO18B	2126	Q8IUG5
CSFEVLWSDSSITSV	ZCCHC14	116	Q8WYQ9
MATSFRTASCWGLLS	ZNF26	1	P17031
RTASCWGLLSFKDIS	ZNF26	6	P17031
ASTDLVTDWTCGLSV	ZNF746	621	Q6NUN9
SVAGSTSSSLCEHWV	USP31	776	Q70CQ4
TTCNSISSVSCIGWS	WDR89	211	Q96FK6
CATSLDSILGSKWSE	ZSWIM1	421	Q9BR11
WETFCTSSLGETNKR	PPP6R3	496	Q5H9R7
TCEKSRTSGLLSSWK	TG	1076	P01266
WSNSTCLKLAVSSRL	TRPM7	716	Q96QT4
TECGKSFSWSSHLIA	ZNF606	571	Q8WXB4
DSWASSPSCSLSLLA	NACAD	226	O15069
ISLSTAHEACWGTSS	N4BP2	921	Q86UW6
WTTCQSIAFPSKTSA	PLP1	181	P60201
GLDTSCRWLSKSTTR	NDE1	316	Q9NXR1